KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Return on Equity: 2009-2024

Historic Return on Equity for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to 0.04%.

  • Dynavax Technologies' Return on Equity fell 12.00% to -0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.08%, marking a year-over-year decrease of 12.00%. This contributed to the annual value of 0.04% for FY2024, which is 6.00% up from last year.
  • As of FY2024, Dynavax Technologies' Return on Equity stood at 0.04%, which was up 521.90% from -0.01% recorded in FY2023.
  • Dynavax Technologies' Return on Equity's 5-year high stood at 0.73% during FY2022, with a 5-year trough of -2.25% in FY2020.
  • For the 3-year period, Dynavax Technologies' Return on Equity averaged around 0.25%, with its median value being 0.04% (2024).
  • Its Return on Equity has fluctuated over the past 5 years, first skyrocketed by 279bps in 2021, then slumped by 74bps in 2023.
  • Over the past 5 years, Dynavax Technologies' Return on Equity (Yearly) stood at -2.25% in 2020, then spiked by 279bps to 0.55% in 2021, then increased by 18bps to 0.73% in 2022, then crashed by 74bps to -0.01% in 2023, then grew by 6bps to 0.04% in 2024.